Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 52.94

Shenzhen Salubris Pharmaceuticals Co., Ltd. experienced a notable decline in its stock performance on October 14, 2025, with a decrease of 5.29%. The stock reached an intraday low of CNY 52.94, reflecting a challenging day for the company within the Pharmaceuticals & Biotechnology sector. Over the past week, Shenzhen Salubris has seen a significant drop of 11.65%, contrasting with a slight gain of 0.17% in the China Shanghai Composite. On a monthly basis, the stock has decreased by 2.25%, while the broader market index has shown a modest increase of 0.49%. Despite the recent downturn, Shenzhen Salubris has demonstrated strong performance over the past year, achieving a return of 52.95%, significantly outperforming the China Shanghai Composite's 20.88% gain. Year-to-date, the company has recorded an impressive 72.39% increase, further highlighting its resilience in the market. With a market capitalization of CNY 61,030 million and a return on equity of 7.28%, Shenzhen Salubris continues to maintain a solid position within its industry, although recent profit trends indicate a decline of 3.2% over the past year.